Evidence map›Paper›PMID 35295130›Full record

ArticleFrontiers in toxicology2021

Prediction of Skin Sensitization Potential of Silver and Zinc Oxide Nanoparticles Through the Human Cell Line Activation Test.

Ravi Gautam, SuJeong Yang, Anju Maharjan, JiHun Jo, Manju Acharya, Yong Heo, ChangYul Kim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ravi GautamDepartment of Occupational Health, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, South Korea.
SuJeong YangDepartment of Occupational Health, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, South Korea.
Anju MaharjanDepartment of Occupational Health, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, South Korea.
JiHun JoDepartment of Occupational Health, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, South Korea.
Manju AcharyaDepartment of Occupational Health, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, South Korea.
Yong HeoDepartment of Occupational Health, College of Bio and Medical Sciences, Daegu Catholic University, Gyeongsan, South Korea.
ChangYul KimDepartment of Toxicity Assessment, The Graduate School of Medical and Health Industry, Daegu Catholic University, Gyeongsan, South Korea.
Catholic University of Daegu · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of nanotechnology has propagated the use of nanoparticles (NPs) in various fields including industry, agriculture, engineering, cosmetics, or medicine. The use of nanoparticles in cosmetics and dermal-based products is increasing owing to their higher surface area and unique physiochemical properties. Silver (Ag) NPs' excellent broad-spectrum antibacterial property and zinc oxide (ZnO) NPs' ability to confer better ultraviolet (UV) protection has led to their maximal use in cosmetics and dermal products. While the consideration for use of nanoparticles is increasing, concerns have been raised regarding their potential negative impacts. Although used in various dermal products, Ag and ZnO NPs' skin sensitization (SS) potential has not been well-investigated using

Indexed as

human cell line activation test (h-CLAT)nanoparticlessilverskin sensitizationzinc oxide

Identifiers

PMID35295130
PMCPMC8915822
OpenAlexW3167809326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.